These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15154101)

  • 1. American Chemical Society--227th annual meeting. Neuroprotection. 28 March - 1 April 2004, Anaheim, CA, USA.
    Rotella DP
    IDrugs; 2004 May; 7(5):430-2. PubMed ID: 15154101
    [No Abstract]   [Full Text] [Related]  

  • 2. Ca2+ channel alpha2-delta ligands for the treatment of neuropathic pain.
    Field MJ; Li Z; Schwarz JB
    J Med Chem; 2007 May; 50(11):2569-75. PubMed ID: 17489571
    [No Abstract]   [Full Text] [Related]  

  • 3. American Chemical Society--227th annual meeting. Diabetes. 28 March - 1 April 2004, Anaheim, CA, USA.
    Rotella DP
    IDrugs; 2004 May; 7(5):428-9. PubMed ID: 15154100
    [No Abstract]   [Full Text] [Related]  

  • 4. American Chemical Society--227th annual meeting. Highlights. 28 March - 1 April 2004, Anaheim, CA, USA.
    Garvey R; Veryard C
    IDrugs; 2004 May; 7(5):426-7. PubMed ID: 15154099
    [No Abstract]   [Full Text] [Related]  

  • 5. American Chemical Society--227th Annual Meeting. NMDA receptor. 28 March - 1 April 2004, Anaheim, CA, USA.
    Rotella DP
    IDrugs; 2004 May; 7(5):433-5. PubMed ID: 15154102
    [No Abstract]   [Full Text] [Related]  

  • 6. American Chemical Society--227th Annual Meeting. Antibacterials and anti-inflammatories. 28 March - 1 April 2004, Anaheim, CA, USA.
    Garvey R; Veryard C
    IDrugs; 2004 May; 7(5):420-2. PubMed ID: 15154097
    [No Abstract]   [Full Text] [Related]  

  • 7. American Chemical Society--227th Annual Meeting. New disclosures. 28 March - 1 April 2004, Anaheim, CA, USA.
    Garvey R; Veryard C
    IDrugs; 2004 May; 7(5):423-5. PubMed ID: 15154098
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregabalin for the treatment of painful neuropathy.
    Sonnett TE; Setter SM; Campbell RK
    Expert Rev Neurother; 2006 Nov; 6(11):1629-35. PubMed ID: 17144773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of neuropathy-induced allodynia following intraplantar injection of pregabalin.
    Park HJ; Joo HS; Chang HW; Lee JY; Hong SH; Lee Y; Moon DE
    Can J Anaesth; 2010 Jul; 57(7):664-71. PubMed ID: 20440664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of paclitaxel-induced peripheral neuropathy successfully treated with pregabalin].
    Nakashima T; Kiba T; Ogawa Y; Hosokawa A; Shintani H; Okada Y; Taniguchi T; Shigeta M; Kozawa K
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1443-5. PubMed ID: 22996788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain.
    Annemans L; Caekelbergh K; Morlion B; Hans G; De Cock P; Marbaix S
    Acta Clin Belg; 2008; 63(3):170-8. PubMed ID: 18714847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of adding pregabalin or gabapentin to the management of community-treated patients with peripheral neuropathic pain.
    Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Planas-Comes A
    J Eval Clin Pract; 2012 Dec; 18(6):1170-9. PubMed ID: 21883712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
    Nymdelger S; Nieber K
    Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids before and after initiation of pregabalin in patients with diabetic peripheral neuropathy.
    Kozma CM; Benson C; Slaton TL; Kim MS; Vorsanger GJ
    Curr Med Res Opin; 2012 Sep; 28(9):1485-96. PubMed ID: 22856535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I can't get no satisfaction: still no neuroprotection for Parkinson disease.
    Ahlskog JE
    Neurology; 2007 Oct; 69(15):1476-7. PubMed ID: 17923609
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregabalin antagonizes copper-induced toxicity in the brain: in vitro and in vivo studies.
    Marmolino D; Manto M
    Neurosignals; 2010; 18(4):210-22. PubMed ID: 21196706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
    Guay DR
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMS-204352 (Bristol Myers Squibb).
    Mackay KB
    Curr Opin Investig Drugs; 2001 Jun; 2(6):820-3. PubMed ID: 11572663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.